Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 15, 1996Journal of Cellular Biochemistry

Heparin-binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cells

View Full Paper
Ask AI
Bookmark
Share

Authors

FIFrancesca IncardonaInforma (Italy)JLJack LawlerBeth Israel Deaconess Medical CenterDCDidier CataldoUniversity of Liège

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Incardona et al. (1996) studied this question.

synapsesocial.com/papers/6aa95d8f1189ba9941879aadhttps://doi.org/10.1002/(sici)1097-4644(19960915)62:4<431::aid-jcb1>3.0.co;2-n
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Thrombospondin Levels in Patients with Malignancy1992 · 77 citations
  2. 2Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis.1995 · 167 citations
  3. 3A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.1990 · 1,063 citations
  4. 4Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines1994 · 217 citations